YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Merck to acquire Terns Pharmaceuticals

Posted online

Merck is set to buy Terns Pharmaceuticals.

The deal is valued at $6.7 billion.

The acquisition will give Merck access to a medicine Terns is developing for a type of leukemia.

Read more from CNBC.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Fall 2026 Architects & Engineers Project Report

This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.

Most Read
Update cookies preferences